Cardiovascular death is a leading cause of death in patients with chronic kidney disease (CKD), while the risk of cardiovascular mortality, adjusted for traditional cardiovascular risk factors and albuminuria, is linearly and negatively correlated with renal function. 1 In particular, cardiovascular mortality in CKD patients who are on dialysis is 10 to 20 times higher than in the general population. 2,3 This increased cardiovascular risk primarily concerns coronary artery disease (CAD), 4 with CKD patients exhibiting high prevalences of traditional cardiovascular risk factors (advanced age, hypertension, diabetes, dyslipidemia) as well as certain uremia-specific risk factors. 5 It should also be borne in mind that the atherosclerotic process in CKD patients can remain highly active even after renal transplantation, with hypertension, hyperlipidemia, and hyperglycemia being further facilitated by immunosuppressant therapy (corticosteroids, calcineurin inhibitors). Indeed, the mortality of CKD patients remains of cardiovascular origin in 35% to 50% of cases after transplantation. 4